Overview of systemic feature symptoms associated with systemic juvenile idiopathic arthritis before and after tocilizumab treatment
| Symptom | Patients reporting symptoms (N=251) | |
|---|---|---|
| Baseline, n (%) | Week 52, n (%) | |
| Fever | 137 (54.6) | 14 (5.6) |
| Rash | 108 (43.0) | 14 (5.6) |
| Cervical lymphadenopathy | 47 (18.7) | 2 (0.8) |
| Hepatomegaly | 27 (10.8) | 10 (4.0) |
| Serositis | 23 (9.2) | 0 (0.0) |
| Splenomegaly | 21 (8.4) | 8 (3.2) |
| Axillary lymphadenopathy | 14 (5.6) | 1 (0.4) |
| Inguinal lymphadenopathy | 11 (4.4) | 0 (0.0) |